骨髓微环境重编程:从病理机制到向治疗策略
Xiaofei Cong1, Xiaohuan Peng2, Xixi Chen2
1Department of Hematology, Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
Frontiers in immunology
|March 12, 2026
概括
骨髓质瘤 (MDS) 涉及骨髓微环境 (BMME) 功能障碍. 针对BMME为MDS患者提供了有前途的新疗法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 骨髓质瘤 (MDS) 是一种克隆性造血干细胞恶性瘤.
- MDS的发病包括遗传异常和骨髓微环境 (BMME) 失调.
- 细胞和非细胞BMME组件在MDS中都是功能障碍的,导致疾病的进展.
研究的目的:
- 系统地审查MDS中BMME的病理特征.
- 阐明BMME功能障碍在MDS发育中的分子机制.
- 讨论MDS的BMME向治疗的最新进展.
主要方法:
- 对MDS中BMME病理特征的文献综述.
- 对BMME功能障碍背后的分子机制的分析.
- 对BMME向治疗策略的临床研究的综述.
主要成果:
- 在MDS中,BMME表现出显著的细胞和非细胞成分功能障碍.
- 异常的BMME通过复杂的细胞间相互作用驱动MDS的启动和进展.
- 针对BMME的新型治疗方法在改善临床结果方面取得了进展.
结论:
- 了解BMME病理和机制对于MDS治疗至关重要.
- 准BMME为MDS提供了新的治疗途径.
- 免疫调节剂,表观遗传调节剂和细胞疗法方面的进展正在改善MDS患者的治疗结果.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K


